학술논문

CT-186 Impact of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in First Complete Remission (CR1) in Addition to FLT3 Inhibition With Quizartinib in Acute Myeloid Leukemia (AML) With FLT3–Internal Tandem Duplication (FLT3-ITD): Results from the QuANTUM-First Trial
Document Type
Abstract
Source
In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S521-S522
Subject
Language
ISSN
2152-2650